Latest Breaking News On - Emergent technologies inc - Page 1 : comparemela.com

Aileron Therapeutics Announces CEO Transition

Current President and Chief Operating Officer, Brian Windsor, Ph.D., appointed Chief Executive OfficerDr. Windsor to lead Aileron into a new era f.

United statesBrian windsorManuel aivadoEmergent technologies incUniversity of texas at austinAileron therapeutics incPharmaceuticals incCompany board of directorsCompany annual report on formExchange commissionLung therapeutics incCurrent presidentChief operating officerChief executiveChief executive officerLung therapeutics

Myrio Therapeutics and Pure MHC Announce Collaboration to Research and Develop Novel, Targeted Antibody-Based Cancer Therapies

Myrio Therapeutics and Pure MHC Announce Collaboration to Research and Develop Novel, Targeted Antibody-Based Cancer Therapies
massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of oklahomaKris looneyWilliam hildebrandPete smithEmergent technologies incUniversity of oklahoma health science centerNational newsMyrio therapeutics pty ltdMassachusetts newswireRetained displayEmergent technologiesChief scientist william hildebrandOklahoma health science

Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies

Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
floridanewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridanewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of oklahomaKris looneyWilliam hildebrandPete smithEmergent technologies incUniversity of oklahoma health science centerMyrio therapeutics pty ltdRetained displayEmergent technologiesChief scientist william hildebrandOklahoma health scienceAlliances and partnershipsDrugs and pharmaceuticalsEmergent technologies incEnetic medicine cancer therapy

Pure MHC LLC and Myrio Announce Collaboration to Research and Develop Targeted Antibody-Based Cancer Therapies

eNewsChannels NEWS: Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC's proprietary offering of MHC peptide targets for oncology with Myrio's revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based on targets distinct to tumors across multiple types of cancer. :: News from eNewsChannels

United statesUniversity of oklahomaKris looneyWilliam hildebrandPete smithEmergent technologies incUniversity of oklahoma health science centerMyrio therapeutics pty ltdRetained displayEmergent technologiesChief scientist william hildebrandOklahoma health science

Pure Transplant Solutions, LLC and Vall d Hebron University Hospital Announce Research Collaboration

AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d'Hebron Barcelona Hospital Campus to develop new technologies for B-cell monitoring in transplant rejection. - News from Pure Transplant Solutions LLC, issued by Send2Press Newswire

Israel generalUnited statesComunidad autonoma de catalunaOriol bestardEmergent technologies incPure proteinPure transplant solutionsHebron university hospitalAutonomous university of barcelonaHebron oncology instituteUniversity of oklahomaSclerosis centerHebron research instituteHebron barcelona hospital campusTransplant solutionsRico buchli